by Extivita | Jan 13, 2017 | Cerebral Palsy
Abstract: To observe the effects of hyperbaric oxygen (HBO2) therapy on the treatment of sleep disorders and its safety in children with cerebral palsy (CP). A total of 71 recruited children were divided into two groups based on age: group 1, aged between 2 and 4...
by Extivita | May 31, 2016 | Cerebral Palsy
Abstract: We examined the effects of mild hyperbaric oxygen on the properties of the soleus muscle in rats with metabolic syndrome. Five-week-old metabolic syndrome (SHR/NDmcr-cp, cp/cp) rats were divided into normobaric (CP) and mild hyperbaric oxygen (CP-H) groups...
by Extivita | Dec 18, 2014 | Cerebral Palsy
Abstract: To assess the mutagenic potential of the oxygen inhalation therapy (HBO), by means of the micronucleus test, performed in peripheral blood of rats that underwent subtotal splenectomy with lower pole preservation (ESTPI), after HBO sessions or simulations....
by Extivita | Oct 26, 2014 | Cerebral Palsy
Abstract: The present study was carried out to evaluate cerebral perfusion in different types of cerebral palsy (CP) patients. For those patients who underwent hyperbaric oxygen therapy, brain perfusion before and after the therapy was compared. A total of 11 CP...
by Extivita | Jul 10, 2014 | Cerebral Palsy
Abstract: Unestablished indications are conditions in which systematic clinical use of hyperbaric oxygen treatment (HBOT) is not supported by adequate proof of benefit. HBOT is vulnerable to use in many such conditions for various reasons, perhaps the most important...
by Extivita | May 24, 2014 | Cerebral Palsy
Abstract: The present study aimed to assess the effect of intensive rehabilitation combined with hyperbaric oxygen (HBO2) therapy on gross motor function in children with cerebral palsy (CP). We carried out an open, observational, platform-independent study in 150...
